These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 27614782)

  • 41. Points to consider about prescription drug prices: an overview of federal policy and pricing studies.
    Kucukarslan S; Hakim Z; Sullivan D; Taylor S; Grauer D; Haugtvedt C; Zgarrick D
    Clin Ther; 1993; 15(4):726-38. PubMed ID: 8221823
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Financing and systems barriers to seasonal influenza vaccine delivery in community settings.
    Penfold RB; Rusinak D; Lieu TA; Shefer A; Messonnier M; Lee GM
    Vaccine; 2011 Dec; 29(52):9632-9. PubMed ID: 22036886
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Medicaid program; payments for services furnished by certain primary care physicians and charges for vaccine administration under the Vaccines for Children program. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2012 Nov; 77(215):66669-701. PubMed ID: 23139946
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Financial requirements of immunisation programmes in developing countries: a 2004-2014 perspective.
    Peny JM; Gleizes O; Covilard JP
    Vaccine; 2005 Aug; 23(37):4610-8. PubMed ID: 15979769
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Modeling the national pediatric vaccine stockpile: supply shortages, health impacts and cost consequences.
    Shrestha SS; Wallace GS; Meltzer MI
    Vaccine; 2010 Aug; 28(38):6318-32. PubMed ID: 20638451
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Value-based performance arrangements for chronic conditions: an economic simulation of Medicaid Drug Rebate Program reforms.
    Quinn C; Ciarametaro M; Sils B; Phares S; Trusheim MR
    Expert Rev Pharmacoecon Outcomes Res; 2023 Jun; 23(5):535-546. PubMed ID: 36987666
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of health economic analyses in vaccine decision making.
    Black S
    Vaccine; 2013 Dec; 31(51):6046-9. PubMed ID: 23968768
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Group purchasing in health care: whose agenda?
    Beste JT; Reed S
    Hosp Mater Manage Q; 1989 May; 10(4):25-35. PubMed ID: 10292941
    [No Abstract]   [Full Text] [Related]  

  • 49. Basic concepts and issues: a primer on distribution and sales representative agreements in the medical device and durable medical equipment industries.
    Burow HE; Kolls RC
    J Health Law; 2006; 39(2):165-230. PubMed ID: 17002232
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New vaccine adoption in lower-middle-income countries.
    Makinen M; Kaddar M; Molldrem V; Wilson L
    Health Policy Plan; 2012 May; 27 Suppl 2():ii39-49. PubMed ID: 22513731
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of tetanus, diphtheria, and acellular pertussis (Tdap) vaccine use in wound management on health care costs and pertussis cases.
    Talbird SE; Graham J; Mauskopf J; Masseria C; Krishnarajah G
    J Manag Care Spec Pharm; 2015 Jan; 21(1):88-99, 99a-c. PubMed ID: 25562776
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Variation in Costs of Spinal Implants in United States Academic Medical Centers.
    Pahlavan S; Berven S; Bederman SS
    Spine (Phila Pa 1976); 2016 Mar; 41(6):515-21. PubMed ID: 26966975
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [A full economic evaluation of extensive vaccination against rotavirus with RIX4414 vaccine at National and Regional level in Italy].
    Vitale F; Barbieri M; Dirodi B; Vitali Rosati G; Franco E
    Ann Ig; 2013; 25(1):43-56. PubMed ID: 23435779
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Designing pediatric vaccine formularies and pricing pediatric combination vaccines using operations research models and algorithms.
    Jacobson SH; Sewell EC; Allwine DA; Medina EA; Weniger BG
    Expert Rev Vaccines; 2003 Feb; 2(1):15-9. PubMed ID: 12901593
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Murphy TV; Slade BA; Broder KR; Kretsinger K; Tiwari T; Joyce PM; Iskander JK; Brown K; Moran JS;
    MMWR Recomm Rep; 2008 May; 57(RR-4):1-51. PubMed ID: 18509304
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Consideration Of Value-Based Pricing For Treatments And Vaccines Is Important, Even In The COVID-19 Pandemic.
    Neumann PJ; Cohen JT; Kim DD; Ollendorf DA
    Health Aff (Millwood); 2021 Jan; 40(1):53-61. PubMed ID: 33211534
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Frequency and causes of vaccine wastage.
    Setia S; Mainzer H; Washington ML; Coil G; Snyder R; Weniger BG
    Vaccine; 2002 Jan; 20(7-8):1148-56. PubMed ID: 11803076
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Optimal Carbon Emission Reduction and Prices with Cap and Trade Mechanism and Competition.
    Zhang L; Zhou H; Liu Y; Lu R
    Int J Environ Res Public Health; 2018 Nov; 15(11):. PubMed ID: 30453588
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Public support in the United States for global equity in vaccine pricing.
    Chan Y; Datt G; Islam A; Rai B; Wang LC
    Sci Rep; 2022 May; 12(1):8960. PubMed ID: 35624169
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Building your business--setting your fees: a cost-based approach.
    Duester KJ
    J Am Diet Assoc; 1997 Oct; 97(10 Suppl 2):S129-30. PubMed ID: 9336573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.